Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers Evaluation and Effect of Mepolizumab on Lower and Upper Airways Inflammation in Severe Refractory Eosinophilic Asthma

NCT05063981 is registered in ClinicalTrials.gov with Istituti Clinici Scientifici Maugeri SpA as lead sponsor.

NCT NCT05063981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05063981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers Evaluation and Effect of Mepolizumab on Lower and Upper Airways Inflammation in Severe Refractory Eosinophilic Asthma
Lead sponsor
Istituti Clinici Scientifici Maugeri SpA
Phase
Observational
Overall status
Completed
Start date
November 25, 2021
Completion date
September 2, 2025
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

severe eosinophilic asthma